Christopher Shea to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Christopher Shea has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.013
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
Score: 0.008
-
Follicular mucinosis as a presenting sign of acute myeloblastic leukemia. J Am Acad Dermatol. 1998 May; 38(5 Pt 2):803-5.
Score: 0.005